Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Pain 1 Neoplasms 1 Cancer Pain 1 Burkitt Lymphoma 1 Agnosia 1

Interventions

blinatumomab 4 Dexamethasone 3 Vincristine 2 Methotrexate 2 Cyclophosphamide 2 venetoclax 1 tocilizumab 1 siltuximab 1 fludarabine phosphate 1 epratuzumab 1 Whole-Body Irradiation 1 Thiotepa 1 Radioimmunodetection 1 Prednisone 1 Melphalan 1 Etoposide 1 Diphenhydramine 1 Daunorubicin 1 Cytarabine 1 Carboplatin 1 Busulfan 1 Asparaginase 1 Antilymphocyte Serum 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Burkitt Lymphoma × Acetaminophen × Clear all

NCT07570173 2026-06-05

MK-1045-005

Merck Sharp & Dohme LLC

Phase 2/3 Recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡